.img-style{heigth:450px;width:450px;}Overview:ConfirmexosomeisolationwithconfidenceWhenyou’rereadytoconfirmthatyou’veisolatedexosomes,stickwiththeexosomeexpertsatSBI.OurExoAbAntibodyKitincludesantibodiestofourofthemostcommonlyusedexosomeMarkers—CD9,CD63,CD81,andHPS70.Theseareallpolyclonalrabbitantibodiesthatrecognizethehuman,mouse,andratformsoftheprotein,andareagreatchoiceforgeneralexosomedetection(ifyouhaveanyquestionsaboutthebestantibodiestouseforyourexosomeproject,we’rereadytohelp!Justemailusattech@systembio.com).And,likeallofourantibodies,theantibodiesinthiskit,includingthegoatanti-rabbitHRPsecondaryantibodies,arerigorouslyvalidatedforexosomedetectionviaWesternblotting.RigorouslyvalidatedHand-pickedselectionExpertexosomesupportChoosetherightantibodyforyourexosomedetectionneedsCat.#AntibodytoNotesLinktoExoCartaentryforthehumanproteinGeneralexosomemarkersEXOAB-CD9A-1CD9TetraspaninExoCarta_928EXOAB-CD63A-1CD63TetraspaninExoCarta_967EXOAB-CD81A-1CD81TetraspaninExoCarta_93185EXOAB-Hsp70A-1HSP70ExoCarta_3303,ExoCarta_3304,ExoCarta_3306,ExoCarta_3308,ExoCarta3310,ExoCarta_3311EXOAB-ALIX-1ALIXProgrammedcelldeath6interactingprotein(PDCD6IP)ExoCarta_10015EXOAB-ANXA5-1ANXA5-1AnnexinA5ExoCarta_308EXOAB-TSG101-1TSG101Tumorsusceptibilitygene101ExoCarta_7251EXOAB-FLOT1-1FLOT-1Flotillin-1ExoCarta_10211Tissue-specificexosomemarkersEXOAB-CXCR4-1CXCR4SpecificforB-cells,T-cells,andplateletsExoCarta_7852EXOAB-EPCAM1-1EpCamSpecificforcancer-derivedexosomesExoCarta_4072EXOAB-VMTN-1VimentinSpecificformesenchymalstemcellsExoCarta_7431Citations:Hsu,YL,etal.(2017)Hypoxiclungcancer-secretedexosomalmiR-23aincreasedangiogenesisandvascularpermeABIlitybytargetingprolylhydroxylaseandtightjunctionproteinZO-1.Oncogene.2017Apr24;.PMID:28436951Hao,YX,etal.(2017)KRASandBRAFmutationsinserumexosomesfrompatientswithcolorectalcancerinaChinesepopulation.OncolLett.2017May1;13(5):3608-3616.PMID:28521461Joy,M,etal.(2017)TheMyocardin-relatedtranscriptionfactorMKLco-regulatesthecellularlevelsoftwoprofilinisoforms.J.Biol.Chem..2017May25;.PMID:28546428LIN,F,etal.(2017)Effectsofesophagealcancercell-derivedexosomesoncancercellmigrationandinvasionanditsmechanismresearch.MedicalJournalofChinesePeople"sLiberationArmy.2017Apr1;42(1):307-.Link:MedicalJournalofChinesePeople"sLiberationArmyYoon,S,etal.(2017)MLKL,theProteinthatMediatesNecroptosis,AlsoRegulatesEndosomalTraffickingandExtracellularVesicleGeneration.Immunity.2017Jun22;.PMID:28666573Dickman,CT,etal.(2017)SelectiveextracellularvesicleexclusionofmiR-142-3pbyoralcancercellspromotesbothinternalandextracellularmalignantphenotypes.Oncotarget.2017Feb28;8(9):15252-15266.PMID:28146434Koh,YQ,etal.(2016)Characterizationofexosomalreleaseinbovineendometrialintercaruncularstromalcells.Reprod.Biol.Endocrinol..2016Nov9;14(1):78.PMID:27829441McNicholas,K,etal.(2016)Albuminuriaisnotassociatedwithelevatedurinaryvesicleconcentrationbutcanconfoundnanoparticletrackinganalysis.Nephrology(Carlton).2016Aug6;.PMID:27496221Fischer,S,etal.(2016)IndicationofHorizontalDNAGeneTransferbyExtracellularVesicles.PLoSONE.2016Sep29;11(9):e0163665.PMID:27684368Wen,S,etal.(2016)Mesenchymalstromalcell-derivedextracellularvesiclesrescuerADIationdamagetomurinemarrowhematopoieticcells.Leukemia.2016Nov1;30(11):2221-2231.PMID:27150009Spencer,B,etal.(2016)α-SynucleininterfereswiththeESCRT-IIIcomplexcontributingtothepathogenesisofLewybodydisease.Hum.Mol.Genet..2016Mar15;25(6):1100-15.PMID:26740557Silvers,CR,etal.(2016)Identificationofextracellularvesicle-borneperiostinasafeatureofmuscle-invasivebladdercancer.Oncotarget.2016Apr26;7(17):23335-45.PMID:26981774Kouwaki,T,etal.(2016)ExtracellularVesiclesIncludingExosomesRegulateInnateImmuneResponsestoHepatitisBVirusInfection.FrontImmunol.2016Sep16;7:335.PMID:27630638Diaz-Hidalgo,L,etal.(2016)Transglutaminasetype2-dependentselectiverecruitmentofproteinsintoexosomesunderstressfulcellularconditions.Biochim.Biophys.Acta.2016Aug1;1863(8):2084-92.PMID:27169926Endo-Munoz,L,etal.(2015)ProgressionofOsteosarcomafromaNon-MetastatictoaMetastaticPhenotypeIsCausallyAssociatedwithActivationofanAutocrineandParacrineuPAAxis.PLoSONE.2015Aug31;10(8):e0133592.PMID:26317203Lee,JC,etal.(2015)Papillarythyroidcancer-derivedexosomescontainmiRNA-146bandmiRNA-222.J.Surg.Res..2015Jun1;196(1):39-48.PMID:25819770Luo,X,etal.(2015)ExosomesareunlikelyinvolvedinintercellularNeftransfer.PLoSONE.2015Apr29;10(4):e0124436.PMID:25919665Kanada,M,etal.(2015)Differentialfatesofbiomoleculesdeliveredtotargetcellsviaextracellularvesicles.Proc.Natl.Acad.Sci.U.S.A..2015Mar24;112(12):E1433-42.PMID:25713383Amorim,M,etal.(2014)Theoverexpressionofasingleoncogene(ERBB2/HER2)alterstheproteomiclandscapeofextracellularvesicles.Proteomics.2014Jun1;14(12):1472-9.PMID:24733759

美国SBI代理

System Biosciences,简称SBI，美国加州湾区新成立的生技公司，致力于独特、创新生物技术之开发，以研发利于基因及蛋白质功能鉴定、研究之崭新方法和工具为宗旨。 现阶段研发重心为RNA干扰（RNAi）研究之相关工具。 System Biosciences (SBI) 致力于开发独特、革新的技术，为客户研究蛋白组学和基因组学功能提供研究工具。SBI 是专业的慢病毒产品公司，提供基于慢病毒

美国SBI代理

ExoQuick and ExoQuick-TC Products

Product	Size	Catalog #
ExoQuick serum exosome precipitation solution (5 ml)	75 reactions	EXOQ5A-1
ExoQuick Plasma prep and Exosome precipitation kit (5 ml ExoQuick plus 500 ul Thrombin at 500U/mL), replaces EXOQ5TD-1 product	75 reactions	EXOQ5TM-1
Thrombin Plasma prep for Exosome precipitation (500 ul at 500U/mL), replaces TDEXO-1 product	100 reactions	TMEXO-1
ExoQuick serum exosome precipitation solution (20 ml)	300 reactions	EXOQ20A-1
ExoQuick-TC for Tissue Culture Media and Urine (10ml)	10 reactions	EXOTC10A-1
ExoQuick-TC for Tissue Culture Media and Urine (50ml)	50 reactions	EXOTC50A-1
Exosome-depleted FBS Media Supplement - USA Certified	50 ml	EXO-FBS-50A-1
Exosome-depleted FBS Media Supplement - USA Certified	250 ml	EXO-FBS-250A-1
ExoQuick-LP Lipoprotein Pre-Clear & Exosome Precipitation Kit	5 reactions	EXOLP5A-1